Embla Medical hf. (LON:0FIW)

Embla Medical Statistics

Total Valuation

Embla Medical has a market cap or net worth of GBP 1.51 billion. The enterprise value is 1.84 billion.

Market Cap	1.51B
Enterprise Value	1.84B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	427.55M
Shares Outstanding	n/a
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	-2.39%
Owned by Insiders (%)	0.08%
Owned by Institutions (%)	71.88%
Float	161.76M

Valuation Ratios

The trailing PE ratio is 24.39 and the forward PE ratio is 20.39.

PE Ratio	24.39
Forward PE	20.39
PS Ratio	2.19
PB Ratio	2.27
P/TBV Ratio	n/a
P/FCF Ratio	18.39
P/OCF Ratio	15.33
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.33, with an EV/FCF ratio of 22.40.

EV / Earnings	29.71
EV / Sales	2.67
EV / EBITDA	13.33
EV / EBIT	18.89
EV / FCF	22.40

Financial Position

The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.60.

Current Ratio	1.48
Quick Ratio	0.83
Debt / Equity	0.60
Debt / EBITDA	3.02
Debt / FCF	4.90
Interest Coverage	6.39

Financial Efficiency

Return on equity (ROE) is 9.98% and return on invested capital (ROIC) is 7.25%.

Return on Equity (ROE)	9.98%
Return on Assets (ROA)	4.77%
Return on Invested Capital (ROIC)	7.25%
Return on Capital Employed (ROCE)	8.78%
Weighted Average Cost of Capital (WACC)	6.46%
Revenue Per Employee	164,485
Profits Per Employee	14,760
Employee Count	4,195
Asset Turnover	0.57
Inventory Turnover	2.27

Taxes

In the past 12 months, Embla Medical has paid 18.05 million in taxes.

Income Tax	18.05M
Effective Tax Rate	22.51%

Stock Price Statistics

The stock price has decreased by -6.74% in the last 52 weeks. The beta is 0.58, so Embla Medical's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-6.74%
50-Day Moving Average	32.21
200-Day Moving Average	35.03
Relative Strength Index (RSI)	44.64
Average Volume (20 Days)	1,158

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Embla Medical had revenue of GBP 690.02 million and earned 61.92 million in profits. Earnings per share was 0.15.

Revenue	690.02M
Gross Profit	429.87M
Operating Income	92.65M
Pretax Income	80.20M
Net Income	61.92M
EBITDA	111.56M
EBIT	92.65M
Earnings Per Share (EPS)	0.15

Balance Sheet

The company has 76.16 million in cash and 402.39 million in debt, with a net cash position of -326.22 million.

Cash & Cash Equivalents	76.16M
Total Debt	402.39M
Net Cash	-326.22M
Net Cash Per Share	n/a
Equity (Book Value)	665.58M
Book Value Per Share	1.55
Working Capital	110.28M

Cash Flow

In the last 12 months, operating cash flow was 98.54 million and capital expenditures -16.40 million, giving a free cash flow of 82.14 million.

Operating Cash Flow	98.54M
Capital Expenditures	-16.40M
Free Cash Flow	82.14M
FCF Per Share	n/a

Margins

Gross margin is 62.30%, with operating and profit margins of 13.43% and 8.97%.

Gross Margin	62.30%
Operating Margin	13.43%
Pretax Margin	11.62%
Profit Margin	8.97%
EBITDA Margin	16.17%
EBIT Margin	13.43%
FCF Margin	11.90%

Dividends & Yields

Embla Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.08%
Shareholder Yield	-0.08%
Earnings Yield	4.10%
FCF Yield	5.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Embla Medical has an Altman Z-Score of 3.06 and a Piotroski F-Score of 5.

Altman Z-Score	3.06
Piotroski F-Score	5